Skip Nav Destination
Issues
1 December 2011
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 0149-5992
EISSN 1935-5548
In this Issue
Original Research
Clinical Care / Education / Nutrition / Psychosocial Research
Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial
Mark Woodward, PHD; Anushka Patel, MD; Sophia Zoungas, MD; Lisheng Liu, MD; Changyu Pan, MD; Neil Poulter, MD; Andrzej Januszewicz, MD; Nikhil Tandon, PHD; Prashant Joshi, MD; Simon Heller, MD; Bruce Neal, MD; John Chalmers, MD
Diabetes Care November 2011, Vol.34, 2491-2495. doi:https://doi.org/10.2337/dc11-0755
Pharmacokinetics and Pharmacodynamics of High-Dose Human Regular U-500 Insulin Versus Human Regular U-100 Insulin in Healthy Obese Subjects
Amparo de la Peña, PHD; Matthew Riddle, MD; Linda A. Morrow, MD; Honghua H. Jiang, PHD; Helle Linnebjerg, PHD; Adam Scott, BS; Khin M. Win, MBBS; Marcus Hompesch, MD; Kenneth F. Mace, PHD; Jennie G. Jacobson, PHD; Jeffrey A. Jackson, MD
Diabetes Care November 2011, Vol.34, 2496-2501. doi:https://doi.org/10.2337/dc11-0721
The LiP (Lifestyle in Pregnancy) Study: A randomized controlled trial of lifestyle intervention in 360 obese pregnant women
Christina A. Vinter, MD; Dorte M. Jensen, PHD; Per Ovesen, DMSC; Henning Beck-Nielsen, DMSC; Jan S. Jørgensen, PHD
Diabetes Care November 2011, Vol.34, 2502-2507. doi:https://doi.org/10.2337/dc11-1150
Contributions of Basal and Postprandial Hyperglycemia Over a Wide Range of A1C Levels Before and After Treatment Intensification in Type 2 Diabetes
Matthew Riddle, MD; Guillermo Umpierrez, MD; Andres DiGenio, MD; Rong Zhou, MD; Julio Rosenstock, MD
Diabetes Care November 2011, Vol.34, 2508-2514. doi:https://doi.org/10.2337/dc11-0632
n-3 Fatty Acids, Ventricular Arrhythmia–Related Events, and Fatal Myocardial Infarction in Postmyocardial Infarction Patients With Diabetes
Daan Kromhout, MPH; Johanna M. Geleijnse, PHD; Janette de Goede, MSC; Linda M. Oude Griep, MSC; Barbara J.M. Mulder, MD; Menko-Jan de Boer, MD; Jaap W. Deckers, MD; Eric Boersma, PHD; Peter L. Zock, PHD; Erik J. Giltay, MD
Diabetes Care November 2011, Vol.34, 2515-2520. doi:https://doi.org/10.2337/dc11-0896
Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus
Francesca Porcellati, MD; Paola Lucidi, MD; Paolo Rossetti, MD; Paola Candeloro, PHD; Anna Marinelli Andreoli, MD; Stefania Marzotti, MD; Patrizia Cioli, RD; Geremia B. Bolli, MD; Carmine G. Fanelli, MD
Diabetes Care November 2011, Vol.34, 2521-2523. doi:https://doi.org/10.2337/dc11-1064
Optimizing Insulin Glargine Plus One Injection of Insulin Glulisine in Type 2 Diabetes in the ELEONOR Study: Similar effects of telecare and conventional self-monitoring of blood glucose on patient functional health status and treatment satisfaction
Antonio Nicolucci, MD; Stefano Del Prato, MD; Giacomo Vespasiani, MD; on behalf of the ELEONOR Study Group
Diabetes Care November 2011, Vol.34, 2524-2526. doi:https://doi.org/10.2337/dc11-0900
Safety and Efficacy of 24-h Closed-Loop Insulin Delivery in Well-Controlled Pregnant Women With Type 1 Diabetes: A randomized crossover case series
Helen R. Murphy, MD; Kavita Kumareswaran, MD; Daniela Elleri, MD; Janet M. Allen, RN; Karen Caldwell, RN; Martina Biagioni, MD; David Simmons, MD; David B. Dunger, MD; Marianna Nodale, MSC; Malgorzata E. Wilinska, PHD; Stephanie A. Amiel, PHD; Roman Hovorka, PHD
Diabetes Care November 2011, Vol.34, 2527-2529. doi:https://doi.org/10.2337/dc11-1430
Epidemiology / Health Services Research
Diabetes, Glycemic Control, and Risk of Tuberculosis: A population-based case-control study
Anne Leegaard, BSC; Anders Riis, MSC; Jette B. Kornum, MD; Julie B. Prahl, MD; Vibeke Ø Thomsen, MSC; Henrik Toft Sørensen, MD; C. Robert Horsburgh, MD; Reimar W. Thomsen, MD
Diabetes Care November 2011, Vol.34, 2530-2535. doi:https://doi.org/10.2337/dc11-0902
Association of Pretransplant Glycemic Control With Posttransplant Outcomes in Diabetic Kidney Transplant Recipients
Miklos Z. Molnar, MD; Edmund Huang, MD; Junichi Hoshino, MD; Mahesh Krishnan, MD; Allen R. Nissenson, MD; Csaba P. Kovesdy, MD; Kamyar Kalantar-Zadeh, MD
Diabetes Care November 2011, Vol.34, 2536-2541. doi:https://doi.org/10.2337/dc11-0906
Risk of Breast Cancer After Onset of Type 2 Diabetes: Evidence of detection bias in postmenopausal women
Diabetes Care November 2011, Vol.34, 2542-2544. doi:https://doi.org/10.2337/dc11-1199
Depressive Symptoms, Antidepressant Medication Use, and Insulin Resistance: The PPP-Botnia Study
Antti-Jussi Pyykkönen, MA; Katri Räikkönen, PHD; Tiinamaija Tuomi, MD; Johan G. Eriksson, MD; Leif Groop, MD; Bo Isomaa, MD
Diabetes Care November 2011, Vol.34, 2545-2547. doi:https://doi.org/10.2337/dc11-0107
Low Glycated Hemoglobin and Liver Disease in the U.S. Population
Diabetes Care November 2011, Vol.34, 2548-2550. doi:https://doi.org/10.2337/dc11-0944
Low Water Intake and Risk for New-Onset Hyperglycemia
Ronan Roussel, MD; Léopold Fezeu, MD; Nadine Bouby, PHD; Beverley Balkau, PHD; Olivier Lantieri, MD; François Alhenc-Gelas, MD; Michel Marre, MD; Lise Bankir, PHD; for the D.E.S.I.R. Study Group
Diabetes Care November 2011, Vol.34, 2551-2554. doi:https://doi.org/10.2337/dc11-0652
Diabetes Prevalence and Care in the Métis Population of Ontario, Canada
Diabetes Care November 2011, Vol.34, 2555-2556. doi:https://doi.org/10.2337/dc11-0945
Association of Serum Leptin Levels With Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes
Ko Hanai, MD; Tetsuya Babazono, MD; Michino Mugishima, MD; Naoshi Yoshida, MD; Izumi Nyumura, MD; Kiwako Toya, MD; Ryotaro Bouchi, MD; Nobue Tanaka, MD; Yasuko Uchigata, MD
Diabetes Care November 2011, Vol.34, 2557-2559. doi:https://doi.org/10.2337/dc11-1039
Emerging Treatments and Technologies
Effects of MK-0941, a Novel Glucokinase Activator, on Glycemic Control in Insulin-Treated Patients With Type 2 Diabetes
Gary E. Meininger, MD; Russell Scott, MD; Maria Alba, MD; Yue Shentu, PHD; Edmund Luo, PHD; Himal Amin, BS; Michael J. Davies, PHD; Keith D. Kaufman, MD; Barry J. Goldstein, MD
Diabetes Care November 2011, Vol.34, 2560-2566. doi:https://doi.org/10.2337/dc11-1200
Autologous Umbilical Cord Blood Transfusion in Young Children With Type 1 Diabetes Fails to Preserve C-Peptide
Michael J. Haller, MD; Clive H. Wasserfall, MS; Maigan A. Hulme, BS; Miriam Cintron, BS; Todd M. Brusko, PHD; Kieran M. McGrail, BS; Theresa M. Sumrall, BS; John R. Wingard, MD; Douglas W. Theriaque, MS; Jonathan J. Shuster, PHD; Mark A. Atkinson, PHD; Desmond A. Schatz, MD
Diabetes Care November 2011, Vol.34, 2567-2569. doi:https://doi.org/10.2337/dc11-1406
Pathophysiology / Complications
Arterial Stiffness Is Associated With Incident Albuminuria and Decreased Glomerular Filtration Rate in Type 2 Diabetic Patients
Ryotaro Bouchi, MD; Tetsuya Babazono, MD; Michino Mugishima, MD; Naoshi Yoshida, MD; Izumi Nyumura, MD; Kiwako Toya, MD; Ko Hanai, MD; Nobue Tanaka, MD; Akiko Ishii, MD; Yasuko Uchigata, MD; Yasuhiko Iwamoto, MD
Diabetes Care November 2011, Vol.34, 2570-2575. doi:https://doi.org/10.2337/dc11-1020
Prolonged Caloric Restriction in Obese Patients With Type 2 Diabetes Mellitus Decreases Plasma CETP and Increases Apolipoprotein AI Levels Without Improving the Cholesterol Efflux Properties of HDL
Yanan Wang, MSC; Marieke Snel, MD; Jacqueline T. Jonker, MD; Sebastiaan Hammer, MD; Hildo J. Lamb, MD; Albert de Roos, MD; A. Edo Meinders, MD; Hanno Pijl, MD; Johannes A. Romijn, MD; Johannes W.A. Smit, MD; Ingrid M. Jazet, MD; Patrick C.N. Rensen, PHD
Diabetes Care November 2011, Vol.34, 2576-2580. doi:https://doi.org/10.2337/dc11-0685
Determinants of Body Fat in Infants of Women With Gestational Diabetes Mellitus Differ With Fetal Sex
Barbara E. Lingwood, PHD; Alexandra M. Henry, BSC; Michael C. d’Emden, PHD; Amanda-Mei Fullerton, BSC; Robin H. Mortimer, MBBS; Paul B. Colditz, DPHIL; Kim-Anh Lê Cao, PHD; Leonie K. Callaway, PHD
Diabetes Care November 2011, Vol.34, 2581-2585. doi:https://doi.org/10.2337/dc11-0728
Serum Level of Endogenous Secretory Receptor for Advanced Glycation End Products and Other Factors in Type 2 Diabetic Patients With Mild Cognitive Impairment
Gang Chen, MD; Liangchun Cai, MD; Bin Chen, MD; Jixing Liang, MD; Fenhui Lin, MD; Liantao Li, MD; Lixiang Lin, MD; Jin Yao, MD; Junping Wen, MD; Huibin Huang, MD
Diabetes Care November 2011, Vol.34, 2586-2590. doi:https://doi.org/10.2337/dc11-0958
A Novel Unstable Mutation in Mitochondrial DNA Responsible for Maternally Inherited Diabetes and Deafness
Sylvie Bannwarth, PHD; Meriame Abbassi; René Valéro, MD; Konstantina Fragaki, PHD; Noémie Dubois, MD; Bernard Vialettes, MD; Véronique Paquis-Flucklinger, MD
Diabetes Care November 2011, Vol.34, 2591-2593. doi:https://doi.org/10.2337/dc11-1012
Urinary Markers of Nucleic Acid Oxidation and Long-Term Mortality of Newly Diagnosed Type 2 Diabetic Patients
Kasper Broedbaek, MD; Volkert Siersma, PHD; Trine Henriksen, PHD; Allan Weimann, PHD; Morten Petersen, MD; Jon T. Andersen, MD; Espen Jimenez-Solem, MD; Elisabeth S. Stovgaard, MD; Lars J. Hansen, PHD; Jan Erik Henriksen, PHD; Steen J. Bonnema, PHD; Niels de Fine Olivarius, MD; Henrik E. Poulsen, DMSC
Diabetes Care November 2011, Vol.34, 2594-2596. doi:https://doi.org/10.2337/dc11-1620
Cardiovascular and Metabolic Risk
Evaluation of Nonfasting Tests to Screen for Childhood and Adolescent Dysglycemia
Joyce M. Lee, MD; Achamyeleh Gebremariam, MS; En-Ling Wu, BA; Jennifer LaRose, BS; James G. Gurney, PHD
Diabetes Care November 2011, Vol.34, 2597-2602. doi:https://doi.org/10.2337/dc11-0827
Elevated Liver Function Enzymes Are Related to the Development of Prediabetes and Type 2 Diabetes in Younger Adults: The Bogalusa Heart Study
Quoc Manh Nguyen, MD; Sathanur R. Srinivasan, PHD; Ji-Hua Xu, MD; Wei Chen, MD; Susan Hassig, DRPH; Janet Rice, PHD; Gerald S. Berenson, MD
Diabetes Care November 2011, Vol.34, 2603-2607. doi:https://doi.org/10.2337/dc11-0919
Postpartum Metabolic Function in Women Delivering a Macrosomic Infant in the Absence of Gestational Diabetes Mellitus
Simone Kew, BSC; Chang Ye, MSC; Mathew Sermer, MD; Philip W. Connelly, PHD; Anthony J.G. Hanley, PHD; Bernard Zinman, MD; Ravi Retnakaran, MD
Diabetes Care November 2011, Vol.34, 2608-2613. doi:https://doi.org/10.2337/dc11-1554
Reviews / Commentaries / ADA Statements
Meta-Analysis
Diabetes and Risk of Parkinson’s Disease: A systematic review and meta-analysis
Emanuele Cereda, MD; Michela Barichella, MD; Carlo Pedrolli, MD; Catherine Klersy, MD; Erica Cassani, MD; Riccardo Caccialanza, MD; Gianni Pezzoli, MD
Diabetes Care November 2011, Vol.34, 2614-2623. doi:https://doi.org/10.2337/dc11-1584
Review
Emerging Applications of Metabolomic and Genomic Profiling in Diabetic Clinical Medicine
Diabetes Care November 2011, Vol.34, 2624-2630. doi:https://doi.org/10.2337/dc11-0837
Errata
Issues and Events
Diabetes Care Electronic Pages
Perspectives on the News
Final “Perspectives on the News”: American Association of Clinical Endocrinology and American Diabetes Association 2011
Diabetes Care November 2011, Vol.34, e176-e181. doi:https://doi.org/10.2337/dc11-1800
Online Letters: Comments and Responses
Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862
Diabetes Care November 2011, Vol.34, e186. doi:https://doi.org/10.2337/dc11-1654
Response to Comment on: McDonald et al. High-Sensitivity CRP Discriminates HNF1A-MODY From Other Subtypes of Diabetes. Diabetes Care 2011;34:1860–1862
Diabetes Care November 2011, Vol.34, e187. doi:https://doi.org/10.2337/dc11-1766
Comment on: Hellemons et al. Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A Post Hoc Analysis of the IRMA-2 Trial. Diabetes Care 2011;34:2078–2083
Diabetes Care November 2011, Vol.34, e188. doi:https://doi.org/10.2337/dc11-1772
